Table of Contents
Sterile compounding is a critical aspect of pharmacy practice, ensuring patients receive safe and effective medications. Compliance with USP 797 and 800 standards is essential to maintain safety, quality, and regulatory adherence. Proper preparation can help pharmacies meet these stringent requirements and avoid costly violations.
Understanding USP 797 and 800
USP 797 provides guidelines for sterile compounding to prevent contamination, ensuring medication safety. USP 800 focuses on hazardous drug handling, emphasizing worker safety and environmental controls. Both standards aim to minimize risks associated with compounded sterile preparations (CSPs).
Key Requirements for Compliance
- Proper facility design and environmental controls
- Staff training and competency validation
- Standard Operating Procedures (SOPs)
- Environmental monitoring and testing
- Personal protective equipment (PPE)
- Correct cleaning and disinfection protocols
- Accurate documentation and record-keeping
Preparing Your Facility
Facility preparation is foundational to compliance. Ensure that your sterile compounding areas are designed according to USP 797 and 800 specifications. This includes controlled air quality, proper airflow patterns, and segregated areas for hazardous and non-hazardous compounding.
Regular maintenance and validation of HVAC systems are critical. Conduct airflow and pressure tests to confirm environmental stability. Implement HEPA filtration and maintain positive or negative pressure environments as required.
Staff Training and Competency
All personnel involved in sterile compounding must undergo comprehensive training. Training should cover aseptic techniques, PPE use, cleaning procedures, and emergency protocols. Regular competency assessments ensure ongoing adherence to standards.
Developing and Implementing SOPs
Standard Operating Procedures are vital for consistency and compliance. SOPs should detail every step of compounding, cleaning, and documentation processes. Regular review and updates are necessary to incorporate new regulations or best practices.
Environmental Monitoring and Testing
Routine environmental monitoring helps detect contamination early. This includes air sampling, surface swabbing, and particulate testing. Maintain logs of all monitoring activities and address any deviations promptly.
Personal Protective Equipment (PPE)
Proper PPE usage is crucial, especially when handling hazardous drugs under USP 800. Ensure availability of gloves, gowns, masks, and eye protection. Train staff on correct donning and doffing procedures to prevent contamination.
Cleaning and Disinfection Protocols
Implement validated cleaning routines using appropriate disinfectants. Focus on high-touch surfaces and equipment. Maintain a cleaning schedule and document all procedures for compliance verification.
Documentation and Record-Keeping
Accurate documentation supports compliance audits and quality assurance. Record all training, environmental monitoring results, cleaning logs, and SOP revisions. Use electronic systems when possible for better traceability.
Continuous Quality Improvement
Regular audits and reviews help identify areas for improvement. Stay updated on regulatory changes and incorporate new best practices. Encouraging a culture of safety and quality ensures ongoing compliance and patient safety.
Conclusion
Preparing for USP 797 and 800 compliance requires a proactive approach involving facility design, staff training, SOP development, and rigorous monitoring. By implementing these strategies, pharmacies can ensure safe, effective, and compliant sterile compounding practices that protect both patients and staff.